SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
xuanxuan
Lv4
430 积分
2021-04-15 加入
最近求助
最近应助
互助留言
Longitudinal Association Between Angina Pectoris and Quality of Life
1天前
已完结
Frequency of angina and quality of life in outpatients with stable coronary artery disease in Turkey: insights from the PULSE study
1天前
已完结
What constitutes an appropriate empirical trial of antianginal therapy in patients with stable angina before referral for revascularisation?
2天前
已完结
Selinexor With Anti-PD-1 Antibody as a Potentially Effective Regimen for Patients With Natural Killer/T-Cell Lymphoma Failing Prior L-Asparaginase and PD-1 Blockade
11天前
已完结
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea
11天前
已完结
Anti-metabolic agent pegaspargase plus PD-1 antibody sintilimab for first-line treatment in advanced natural killer T cell lymphoma
11天前
已完结
Combination of anti-PD-1 antibody with P-GEMOX as a potentially effective immunochemotherapy for advanced natural killer/T cell lymphoma
11天前
已完结
Combination of Anti-PD-1 Antibody, Anlotinib and Pegaspargase “Sandwich” With Radiotherapy in Localized Natural Killer/T Cell Lymphoma
11天前
已完结
First-line sintilimab with pegaspargase, gemcitabine, and oxaliplatin in advanced extranodal natural killer/T cell lymphoma (SPIRIT): a multicentre, single-arm, phase 2 trial
12天前
已完结
Intensive therapy can improve long‐term survival in newly diagnosed, advanced‐stage extranodal NK/T‐cell lymphoma: A multi‐institutional, real‐world study
12天前
已完结
没有进行任何应助
感谢
1天前
感谢
1天前
感谢
2天前
感谢
11天前
感谢
11天前
感谢
11天前
感谢
11天前
感谢
11天前
点赞
12天前
感谢
12天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论